Showing results (241-250 of 382) with videos related to

Sort By:
Pageof 39
Metabolic Syndrome and Related Disorders|June 5, 2015
Nonalcoholic Fatty Liver: The Association with Metabolic Abnormalities, Body Mass Index and Central Obesity--A Population-Based StudyMohammad Reza Ostovaneh, Farhad Zamani, Alireza Ansari-Moghaddam, et al.
European Journal of Cardiovascular Nursing|February 23, 2021
Association of anthropometric indices with cardiovascular disease risk factors among adults: a study in IranMohammadreza Tabary, Bahman Cheraghian, Zahra Mohammadi, et al.
Drug and Alcohol Dependence Reports|September 24, 2025
Opioid biomarkers in urine as reliable and valid correlates of opium use characteristics: A 10-year longitudinal assessmentMahdokht Naghash, Rebecca L Shaner, Hossein Poustchi, et al.
International Journal of Epidemiology|April 28, 2017
Oral health and mortality in the Golestan Cohort StudyEmily Vogtmann, Arash Etemadi, Farin Kamangar, et al.
International Journal of Cancer|August 7, 2024
One-carbon metabolism biomarkers and upper gastrointestinal cancer in the Golestan Cohort StudyMaki Inoue-Choi, Neal D Freedman, Arash Etemadi, et al.
BMC Psychiatry|December 22, 2023
Prevalence and determinants of opioid use disorder among long-term opiate users in Golestan Cohort StudySaba Alvand, Masoumeh Amin-Esmaeili, Hossein Poustchi, et al.
Plos One|May 27, 2015
The clinical performance of an office-based risk scoring system for fatal cardiovascular diseases in North-East of IranSadaf G Sepanlou, Reza Malekzadeh, Hossein Poustchi, et al.
Plos One|May 4, 2017
Prevalence and determinants of chronic kidney disease in northeast of Iran: Results of the Golestan cohort studySadaf G Sepanlou, Hamid Barahimi, Iraj Najafi, et al.
Cancer Science|July 22, 2014
Prediagnostic serum levels of inflammatory biomarkers are correlated with future development of lung and esophageal cancerBrieze R Keeley, Farhad Islami, Akram Pourshams, et al.
Harm Reduction Journal|October 21, 2020
Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals eraSanam Hariri, Heidar Sharafi, Mahdi Sheikh, et al.
Pageof 39